Lithium
INDICATIONS
FDA
FDA
- Bipolar affective disorder type I (acute manic and mixed episodes, maintenance) in patients > 7 years old
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Bipolar depression, treatment-resistant depression, management of clozapine-associated neutropenia
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 3, 2025
Citation
Weinstein, Sujin L. "Lithium." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787448/6.2/Lithium.
Weinstein SL. Lithium. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787448/6.2/Lithium. Accessed October 8, 2025.
Weinstein, S. L. (2025). Lithium. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787448/6.2/Lithium
Weinstein SL. Lithium [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787448/6.2/Lithium.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lithium
ID - 787448
A1 - Weinstein,Sujin,Pharm.D., BCPP
Y1 - 2025/10/03/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787448/6.2/Lithium
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -